NEO-201 is a humanized antibody targeting CEACAM6/CD66c with antitumor activity that binds to tumor-associated variants of carcinoembryonic antigen-associated cellular adhesion molecule (CEACAM)-5 and CEACAM-6, and can be used in the study of breast cancer.
Purity:
99.10%
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
